Village Pharmacy

CLOSEOUT LETTER Village Pharmacy MARCS-CMS 516174 — February 01, 2021 More Warning Letters Warning Letters About Warning and Close-Out Letters Delivery Method: Electronic Email Reference #: #17-NWJ-10 Product: Drugs Recipient: Recipient Name Ann Ervin Recipient Title Owner Village Pharmacy 1280 Yardville-Allentown Road Allentown , NJ 08501-1830 United States ann@thevillagepharmacy.com Issuing Office: New Jersey District Office United States (973) 331-4900 Dear Ms. Ervin: The U.S. Food and Drug Administration (FDA) has completed an evaluation of your firm’s corrective actions in response to our warning letter #17-NWJ-10, dated October 30, 2017. Based on our evaluation, it appears that you have adequately addressed the violations contained in this warning letter. You are expected to take all necessary steps to ensure compliance with the Federal Food, Drug, and Cosmetic Act and FDA’s implementing regulations. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means. Sincerely, /S/ Diana Amador-Toro Program Division Director/District Director Office of Pharmaceutical Quality Operations Division I/New Jersey District Office Content current as of: 02/12/2021 Regulated Product(s) Drugs